Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical
Valentina Vignali appointed as Investment Associate
Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital. At her previous roles she conducted fund and direct investments due diligence. Valentina will support the business
Looking for an Investment Analyst
Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and
Timo Koopmans appointed as new Investment Manager of Utrecht Health Seed Fund
The Utrecht Health Seed Fund is happy to announce the start of its new Investment Manager: Timo Koopmans. Timo holds a PhD in medicinal chemistry from Utrecht University and as a startup founder himself, understands the challenges young companies face. Furthermore he has experience at a management & innovation consultancy
Moveshelf raises €1.7M to accelerate growth and international sales of its Information System for Movement Disorders
Utrecht, The Netherlands Moveshelf is a private digital health company which supplies a novel information system for movement and musculoskeletal disorders. With Moveshelf’s certified Software-as-a-Service, healthcare organizations unlock use of mobility measurements in clinical settings, store data from cameras and wearables in one secure place and allow their medical teams
Cresco Spine closes seed investments to develop innovative dynamic surgical therapy for scoliosis
June 24, 2022 – Utrecht, the Netherlands Cresco Spine, a new player in the spinal arena and a spin-off of the University Medical Center Utrecht (the Netherlands), today announced that it raised seed investments from InSpine and Utrecht Health Seed Fund (UHSF) to continue its development of their unique surgical
TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients
Our portfolio company Targed Biopharmaceuticals raised Series A financing of € 39 million to develop improved treatments for thrombotic diseases. The financing was co-led by Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors First, Curie Capital and UHSF. Congratulations to
Utrecht Health Seed Fund’s first anniversary!
Before we knew, we’re celebrating Utrecht Health Seed Fund’s first anniversary! And what a year it has been. We can’t express how proud we are of our exceptional portfolio companies and the talented entrepreneurs and scientists driving these ventures: – TargED Biopharmaceuticals is developing a next generation clot-busting drug with